Giftify, Inc. Announces Smart Savings Solution for Popular GLP-1 Diabetes and Weight Loss Medications
Giftify (NASDAQ:GIFT) announced that its subsidiary CardCash.com is launching a smart savings solution for expensive GLP-1 weight loss medications like Ozempic and Zepbound through discounted pharmacy gift cards from major retailers including CVS and Walgreens.
The program aims to reduce out-of-pocket expenses for these increasingly popular medications by allowing consumers to combine discounted gift cards with manufacturer savings programs and prescription discount services like GoodRx and SingleCare. According to a Trustpilot reviewer, the solution can generate savings of about $30 per month on Ozempic purchases.
The initiative addresses the growing market demand for GLP-1 medications while expanding Giftify's digital savings platforms into the healthcare sector. The company sees this as an opportunity to demonstrate its business model's versatility in high-growth consumer markets.
Giftify (NASDAQ:GIFT) ha annunciato che la sua filiale CardCash.com lancerà una soluzione di risparmio intelligente per i costosi farmaci per la perdita di peso GLP-1 come Ozempic e Zepbound, attraverso carte regalo scontate delle principali farmacie, tra cui CVS e Walgreens.
Il programma mira a ridurre le spese di tasca per questi farmaci sempre più popolari, consentendo ai consumatori di combinare carte regalo scontate con programmi di risparmio dei produttori e servizi di sconto sulle prescrizioni come GoodRx e SingleCare. Secondo un recensore di Trustpilot, la soluzione può generare risparmi di circa $30 al mese sugli acquisti di Ozempic.
L'iniziativa risponde alla crescente domanda di mercato per i farmaci GLP-1, espandendo al contempo le piattaforme di risparmio digitale di Giftify nel settore sanitario. L'azienda vede questa come un'opportunità per dimostrare la versatilità del proprio modello di business nei mercati dei consumatori in rapida crescita.
Giftify (NASDAQ:GIFT) anunció que su filial CardCash.com lanzará una solución de ahorro inteligente para costosos medicamentos para la pérdida de peso GLP-1 como Ozempic y Zepbound, a través de tarjetas de regalo de farmacia con descuento de importantes minoristas, incluyendo CVS y Walgreens.
El programa tiene como objetivo reducir los gastos de bolsillo para estos medicamentos cada vez más populares, permitiendo a los consumidores combinar tarjetas de regalo con descuento con programas de ahorro de fabricantes y servicios de descuento de recetas como GoodRx y SingleCare. Según un revisor de Trustpilot, la solución puede generar ahorros de aproximadamente $30 al mes en compras de Ozempic.
La iniciativa aborda la creciente demanda del mercado por medicamentos GLP-1, mientras expande las plataformas de ahorro digital de Giftify en el sector de la salud. La empresa ve esto como una oportunidad para demostrar la versatilidad de su modelo de negocio en mercados de consumo de alto crecimiento.
Giftify (NASDAQ:GIFT)는 자회사인 CardCash.com이 Ozempic 및 Zepbound와 같은 비싼 GLP-1 체중 감소 약물에 대한 스마트 절약 솔루션을 출시한다고 발표했습니다. 이 솔루션은 CVS 및 Walgreens와 같은 주요 소매업체의 할인 약국 기프트 카드로 제공됩니다.
이 프로그램은 소비자들이 할인된 기프트 카드를 제조사 절약 프로그램 및 GoodRx 및 SingleCare와 같은 처방전 할인 서비스와 결합할 수 있도록 하여 이러한 점점 더 인기 있는 약물에 대한 본인 부담 비용을 줄이는 것을 목표로 합니다. Trustpilot 리뷰어에 따르면 이 솔루션은 Ozempic 구매 시 월 약 $30의 절약을 생성할 수 있습니다.
이 이니셔티브는 GLP-1 약물에 대한 증가하는 시장 수요를 해결하며 Giftify의 디지털 절약 플랫폼을 의료 분야로 확장합니다. 회사는 이것을 고성장 소비자 시장에서 비즈니스 모델의 다양성을 입증할 수 있는 기회로 보고 있습니다.
Giftify (NASDAQ:GIFT) a annoncé que sa filiale CardCash.com lancera une solution d'épargne intelligente pour les coûteux médicaments de perte de poids GLP-1 comme Ozempic et Zepbound, grâce à des cartes-cadeaux de pharmacie à prix réduit provenant de grands détaillants tels que CVS et Walgreens.
Le programme vise à réduire les dépenses de poche pour ces médicaments de plus en plus populaires en permettant aux consommateurs de combiner des cartes-cadeaux à prix réduit avec des programmes d'épargne des fabricants et des services de réduction d'ordonnance comme GoodRx et SingleCare. Selon un critique de Trustpilot, la solution peut générer des économies d'environ 30 $ par mois sur les achats d'Ozempic.
Cette initiative répond à la demande croissante du marché pour les médicaments GLP-1 tout en élargissant les plateformes d'épargne numérique de Giftify dans le secteur de la santé. L'entreprise considère cela comme une opportunité de démontrer la polyvalence de son modèle commercial sur des marchés de consommation à forte croissance.
Giftify (NASDAQ:GIFT) hat angekündigt, dass ihre Tochtergesellschaft CardCash.com eine intelligente Einsparlösung für teure GLP-1-Abnehmmedikamente wie Ozempic und Zepbound durch vergünstigte Apotheken-Geschenkkarten von großen Einzelhändlern wie CVS und Walgreens einführt.
Das Programm zielt darauf ab, die Eigenkosten für diese zunehmend beliebten Medikamente zu senken, indem es den Verbrauchern ermöglicht, vergünstigte Geschenkkarten mit Herstellersparprogrammen und Rezeptrabattdiensten wie GoodRx und SingleCare zu kombinieren. Laut einem Trustpilot-Rezensenten kann die Lösung Einsparungen von etwa 30 USD pro Monat beim Kauf von Ozempic generieren.
Die Initiative spricht die wachsende Marktnachfrage nach GLP-1-Medikamenten an und erweitert gleichzeitig die digitalen Einsparungsplattformen von Giftify in den Gesundheitssektor. Das Unternehmen sieht dies als eine Gelegenheit, die Vielseitigkeit seines Geschäftsmodells in wachstumsstarken Verbrauchermärkten zu demonstrieren.
- Expansion into high-growth healthcare market through GLP-1 medication savings program
- Creation of new revenue stream through pharmacy gift card sales
- Demonstrated customer value proposition with $30 monthly savings example
- None.
Insights
This strategic initiative positions Giftify at the intersection of two significant market opportunities: the booming GLP-1 medication market and digital healthcare cost management solutions. The GLP-1 medication market is experiencing unprecedented growth, with analysts projecting it to reach
The business model demonstrates several compelling advantages:
- Leverages existing infrastructure and relationships with major pharmacy retailers
- Creates a recurring revenue opportunity as GLP-1 medications require ongoing prescriptions
- Positions CardCash.com as a healthcare savings destination, potentially driving increased transaction volume and user engagement
- Offers stackable savings through integration with other discount programs, enhancing value proposition
The strategy's timing is particularly advantageous given the current healthcare cost containment dialogue and increasing consumer adoption of digital savings tools. However, success will depend on several factors:
- Maintaining adequate inventory of pharmacy gift cards to meet demand
- Building awareness among the target demographic of GLP-1 medication users
- Managing potential regulatory considerations around healthcare-related transactions
- Scaling operations to handle increased transaction volume
This expansion could significantly impact Giftify's market positioning and revenue growth. The average monthly savings of
CardCash.com to Offer Cost-Effective Solutions for High-Demand GLP-1 Medications as Prescription Drug Market Grows
SCHAUMBURG, IL / ACCESS Newswire / February 20, 2025 / Giftify, Inc. (NASDAQ:GIFT) (the "Company"), the owner and operator of CardCash.com and Restaurant.com, and a leader in the incentives and rewards industry, today announced that CardCash.com is offering consumers smart saving solutions for high-cost GLP-1 weight loss prescription medications like Ozempic (semaglutide) from Novo Nordisk and Zepbound (tirzepatide) from Eli Lilly.
CardCash.com, Giftify's secondary gift card exchange platform, provides consumers with an innovative approach to reduce rising out-of-pocket expenses for increasingly popular GLP-1 medications. The strategy leverages discounted pharmacy gift cards from major retailers including CVS and Walgreens.
This program aligns with current national efforts to address healthcare affordability challenges. By providing practical tools to reduce prescription costs, CardCash.com is contributing to the ongoing public dialogue around making essential medications more accessible for all Americans, particularly as policymakers continue to explore comprehensive solutions to rising healthcare expenses.
Consumer feedback validates the financial impact of this approach. "As one Trustpilot reviewer, Corey Polk, shared, ‘I had significant savings on my Walgreens cards. I used it to buy Ozempic, and now I save about
The platform's strategy creates a multi-layered savings opportunity for medication purchasers. Users can combine CardCash's discounted gift cards with manufacturer savings programs and prescription discount services like GoodRx and SingleCare. Additional cost reductions can be achieved through price comparisons between major pharmacy retailers including CVS, Walgreens, and Walmart.
This healthcare cost reduction initiative addresses growing market demand for GLP-1 medications such as Ozempic, Mounjaro, and Wegovy. By providing access to discounted gift cards that can be applied toward pharmaceutical purchases, CardCash extends Giftify's value proposition into the healthcare sector.
"As prescription medication costs continue to rise, we're leveraging our established gift card marketplace to create meaningful savings opportunities in healthcare," said Ketan Thakker, CEO of Giftify, Inc. "This initiative aligns perfectly with our strategic focus on expanding our digital savings platforms into high-growth consumer markets. The increasing adoption of GLP-1 medications represents a significant opportunity to demonstrate the versatility and value of our business model."
About Giftify, Inc.
Giftify, Inc. is a pioneer in the incentive and rewards industry with a focus on retail, dining & entertainment experiences, as the owner and operator of leading digital platforms, CardCash.com and Restaurant.com. CardCash.com is a leading secondary gift card exchange platform, allowing consumers and retailers to realize value by buying and selling gift cards at various scales. Its Restaurant.com is the nation's largest restaurant-focused digital deals brand. Restaurant.com and our Corporate Incentives division connect digital consumers, businesses and communities offering thousands of dining, retail and entertainment deals options nationwide at over 184,000 restaurants and retailers. Restaurant.com prides itself on offering the best deal, every meal. Our gift cards and restaurant certificates allow customers to save at thousands of restaurants across the country with just a few clicks.
For more information, visit: www.giftifyinc.com and www.cardcash.com and https://www.restaurant.com.
Forward-Looking Statements
Press Releases may include forward-looking statements. In particular, the words "believe," "may," "could," "should," "expect," "anticipate," "estimate," "project," "propose," "plan," "intend," and similar conditional words and expressions are intended to identify forward-looking statements. Any statements made in this news release about an action, event or development, are forward-looking statements. Such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the company. Accordingly, you should not place undue reliance on these forward-looking statements. Although the company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that its forward-looking statements will prove to be correct. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. The forward-looking statements in this press release are made as of the date hereof. The company takes no obligation to update or correct its own forward-looking statements, except as required by law or those prepared by third parties that are not paid by the company. Statements in this press release that are not historical fact may be deemed forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Giftify, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Giftify, Inc. is unable to give any assurance that its expectations will be attained. Factors that could cause actual results to differ materially from expectations include the company's ability to identify a suitable business model for the corporation.
Investors Contacts:
SOURCE: Giftify Inc.
View the original press release on ACCESS Newswire
FAQ
How much can consumers save on Ozempic using Giftify's CardCash.com platform?
Which pharmacy retailers are included in GIFT's GLP-1 medication savings program?
What GLP-1 medications are covered by Giftify's CardCash.com savings program?
Can GIFT's CardCash.com savings be combined with other discount programs?
